罕见病知识库 RareSeen

隆凸性皮肤纤维肉瘤

Dermatofibrosarcoma protuberans

定义 英文原文(暂无中文)

Dermatofibrosarcoma protuberans (DFSP) is a rare infiltrating soft tissue sarcoma, generally of low grade malignancy, arising from the dermis of the skin and characteristically associated with a specific chromosomal translocation t(17;22).

别名

DFSP

基本事实

遗传方式
不适用
发病年龄
各年龄段
患病率
1-5 / 10 000(Europe)

相关基因 2

基因名称关联类型
COL1A1collagen type I alpha 1 chainPart of a fusion gene in
PDGFBplatelet derived growth factor subunit BPart of a fusion gene in

临床表型 8

极常见 99–80%5

  • 红斑 HP:0010783
  • 纤维肉瘤 HP:0100244
  • 皮肤肿瘤 HP:0008069
  • 皮下结节 HP:0001482
  • 皮肤增厚 HP:0001072

常见 79–30%1

  • 皮肤溃疡 HP:0200042

偶见 29–5%1

  • 疼痛 HP:0012531

罕见 <4–1%1

  • 淋巴结肿大 HP:0002716

近两年的全球研究 720L2

2024/08 起在 Europe PMC 检索所得,按发表时间倒序显示最近 20 篇。标题未译成中文——自动翻译需要接入 LLM 服务,尚未引入。

  • 2026-08病例报告
    Lesions Reported as Plaque-Like CD34-Positive Dermal Fibroma Reveal Two Reproducible Clinicopathologic Patterns: Two Cases and Literature Review
    Journal of cutaneous pathology · DOI · Europe PMC
  • 2026-08病例报告
    PDGFD-Rearranged Dermatofibrosarcoma Protuberans With S100 and Pan-TRK Expression
    Journal of cutaneous pathology · DOI · Europe PMC
  • 2026-07
    A High-Grade CD34-Positive Spindle Cell Sarcoma of the Palm Revealing an Unexpected TPM3::NTRK1 Fusion: A Diagnostic Pitfall With Major Therapeutic Implications
    Applied immunohistochemistry & molecular morphology : AIMM · DOI · Europe PMC
  • 2026-07病例报告
    Dermatofibrosarcoma protuberans following penetrating trauma: Case report
    Radiology case reports · DOI · Europe PMC
  • 2026-07
    Diagnostic Pitfalls of Morphological Mimicry and CD34 Heterogeneity in Recurrent or Fibrosarcomatous Dermatofibrosarcoma Protuberans: A Clinicopathological Analysis of Three Molecularly Confirmed Cases With Literature Review
    Journal of cutaneous pathology · DOI · Europe PMC
  • 2026-07
    Tumor Characteristics, Subclinical Extent, and Time to Poor Outcomes for less Common Skin Cancers
    Dermatologic surgery : official publication for American Society for D · DOI · Europe PMC
  • 2026-07
    Recurrent TNC::PDGFD Fusions in Ossifying Plexiform Tumors of the Skin
    Modern pathology : an official journal of the United States and Canadi · DOI · Europe PMC
  • 2026-07
    Mechanism of MEK1 phosphorylation by the N-terminal acidic motif-mediated asymmetric BRAF dimer
    Molecular cell · DOI · Europe PMC
  • 2026-07病例报告
    Fibrosarcomatous Transformation of Recurrent Thigh Dermatofibrosarcoma Protuberans Presenting With Spontaneous Hemorrhage
    Plastic and reconstructive surgery. Global open · DOI · Europe PMC
  • 2026-07
    Impact of Dermatology Access on Dermatofibrosarcoma Protuberans Outcomes
    Dermatologic surgery : official publication for American Society for D · DOI · Europe PMC
  • 2026-07
    MRI-Based Surgical Margin Assessment in Dermatofibrosarcoma Protuberans: Correlation With Pathological Extent
    The Journal of dermatology · DOI · Europe PMC
  • 2026-07综述
    Mechanisms of Local Aggressiveness Without Metastasis in Dermatofibrosarcoma Protuberans
    Anticancer research · DOI · Europe PMC
  • 2026-07
    Neoadjuvant BO-112 and Hypofractionated Radiation Therapy with or without Nivolumab in Soft-Tissue Sarcoma: Preclinical and Phase I Results
    Cancer discovery · DOI · Europe PMC
  • 2026-06
    Proteomics-based approach reveals the involvement of spliceosomal components SF3B and SerpinB9 in dermatofibrosarcoma protuberans
    Orphanet journal of rare diseases · DOI · Europe PMC
  • 2026-06
    Congenital Atrophic Dermatofibrosarcoma Protuberans: A Case Report and Narrative Review of the Literature
    Clinical case reports · DOI · Europe PMC
  • 2026-06病例报告
    The 'CIED Team' Approach to Device-Related Complications
    JACC. Case reports · DOI · Europe PMC
  • 2026-06
    Colonic metastasis of dermatofibrosarcoma protuberans detected by colonoscopy
    Clinical journal of gastroenterology · DOI · Europe PMC
  • 2026-06开放获取
    Sorafenib Restores Pentose Phosphate Pathway-Related Redox Homeostasis via the c-Raf/HSP90/G6PD Axis in Hepatic Ischemia-Reperfusion Injury
    MedComm · DOI · Europe PMC
  • 2026-06病例报告
    Spindle cell hemangioma of the lower abdominal wall mimicking dermatofibrosarcoma protuberans: A case report
    JAAD case reports · DOI · Europe PMC
  • 2026-06病例报告
    Durable control of recurrent dermatofibrosarcoma protuberans using wide-margin Mohs micrographic surgery and flap reconstruction without adjuvant radiotherapy: a case report and literature review
    International journal of surgery case reports · DOI · Europe PMC

境外已获批用于本病的药物 1L2

欧盟 0 项、美国 1 项。同一药物在两地各批一次的,会分别列出。

「境外已获批」不等于「在中国能用」。中间隔着进口注册、临床急需境外新药通道、海南博鳌乐城国际医疗旅游先行区等几条路径,各有各的条件与费用。这一节能确定地告诉你的只有一件事:这个病在世界范围内已经有获得批准的药物,它叫什么名字。拿这个名字去问主治医生,是下一步最省力的做法。

药名一律保留英文原文,不作翻译——中国的药品通用名与英文名的音译经常不一致,译错会让人去找一个不存在的药。

数据来自欧洲药品管理局(EMA)的药品与孤儿药资格公开导出表,以及美国 FDA 孤儿药资格数据库。两边口径不同:欧盟一侧取的是当前状态仍为「已授权」的药品;美国一侧记录的是「曾获批准」这一事实,FDA 的公开表不追踪药物此后是否退市(例如 Relyvrio 于 2024 年撤市,表中仍记为已获批)。请以官方记录页为准。

中国境外的在招试验 9L2

这些试验在中国没有研究中心,通常无法直接报名——入组一般要求在当地居住并接受随访。列在这里是因为它另有用处:看清楚全世界正在试哪些药、做到了哪一期、由谁在做。把药名和 NCT 编号记下来去问主治医生,或据此进一步查该药是否已在境外获批、是否有拓展性用药(expanded access)通道。

美国4挪威2澳大利亚1英国1

共 9 项。

  • 尚未开始招募NCT07646080
    Exploratory Study on Toripalimab and Anlotinib Combined With Standard Chemotherapy for Refractory Dermatofibrosarcoma Protuberans
    II 期 · 干预性 · 2026/06/15Yanjie Zhang, MD
  • 招募中NCT07173972
    Dose-escalated, Hypofractionated, Definitive Proton Radiotherapy for Patients With Inoperable Soft Tissue Sarcoma.
    II 期 · 干预性 · 2026/01/26Oslo University Hospital
    挪威
  • 招募中NCT07169344
    Hypofractionated, 3-week, Preoperative Proton or X-ray Radiotherapy for Patients With Localized Soft Tissue Sarcoma
    II 期 · 干预性 · 2026/01/26Oslo University Hospital
    挪威
  • 尚未开始招募NCT06526897
    Evaluation of Chest CT Versus Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk Truncal-Extremity Soft Tissue Sarcoma
    不适用 · 干预性 · 2025/01/28ECOG-ACRIN Cancer Research Group
  • 招募中NCT06789172
    A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
    I 期 · 干预性 · 2025/01/23Epkin
    澳大利亚、英国、美国
  • 尚未开始招募NCT06610071
    NIFR Image-guided Surgery for Malignant Soft Tissue Tumor With Low-dose SWIG Technique
    I 期 · 干预性 · 2024/10/30The Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
  • 招募中NCT06239272
    NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
    I 期、II 期 · 干预性 · 2024/03/27St. Jude Children's Research Hospital
    美国
  • 招募中NCT05711615
    Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
    I 期 · 干预性 · 2024/02/06National Cancer Institute (NCI)
    美国
  • 招募中NCT04332874
    A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg
    II 期 · 干预性 · 2020/04/01Memorial Sloan Kettering Cancer Center
    美国

外部标识与链接

发现这一页有错误?告诉我 · 邮件主题会自动带上本页的 ORPHA 编号

本页数据来源

  • 疾病定义、同义词、基因、表型、流行病学:Orphanet(CC BY 4.0)
  • 中文病名:Orphanet 中文包,冻结于 2020-06-01
  • 表型中文标签:HPO 简体中文翻译(CHPO 上游成果)